1.Zaza G, Granata S, Rascio F, Pontrelli P, Dell’Oglio MP, Cox SN, Pertosa G, Grandaliano G, Lupo A: A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients. BMC Med Genomics 2013, 6:17.
2.Levey AS, Becker C, Inker LA: Glomerular Filtration Rate and Albuminuria for Detection and Staging of Acute and Chronic Kidney Disease in Adults: A Systematic Review. Jama 2015, 313:837.
3.Reddy MA, Natarajan R: Recent developments in epigenetics of acute and chronic kidney diseases. Kidney Int 2015, 88:250–261.
4.Nony PA, Schnellmann RG: Mechanisms of renal cell repair and regeneration after acute renal failure. J Pharmacol Exp Ther 2003, 304:905–912.
5.Garrett SH, Clarke K, Sens DA, Deng Y, Somji S, Zhang KK: Short and long term gene expression variation and networking in human proximal tubule cells when exposed to cadmium. BMC Med Genomics 2013, 6 Suppl 1:S2.
6.Böttinger EP, Bitzer M: TGF-ß Signaling in Renal Disease. Journal of the American Society of Nephrology 2002, 13:2600–2610.
7.Wang Z, Lyu Z, Pan L, Zeng G, Randhawa P: Defining housekeeping genes suitable for RNA-seq analysis of the human allograft kidney biopsy tissue. BMC Med Genomics 2019, 12:86.
8.Xia L, Su X, Shen J, Meng Q, Yan J, Zhang C, Chen Y, Wang H, Xu M: ANLN functions as a key candidate gene in cervical cancer as determined by integrated bioinformatic analysis. Cancer Manag Res 2018, 10:663–670.
9.Olbryt M, Habryka A, Student S, Jarzab M, Tyszkiewicz T, Lisowska KM: Global gene expression profiling in three tumor cell lines subjected to experimental cycling and chronic hypoxia. PLoS One 2014, 9:e105104.
10.Krochmal M, Kontostathi G, Magalhaes P, Makridakis M, Klein J, Husi H, Leierer J, Mayer G, Bascands JL, Denis C, et al: Urinary peptidomics analysis reveals proteases involved in diabetic nephropathy. Sci Rep 2017, 7:15160.
11.Kupfer P, Guthke R, Pohlers D, Huber R, Koczan D, Kinne RW: Batch correction of microarray data substantially improves the identification of genes differentially expressed in rheumatoid arthritis and osteoarthritis. BMC Med Genomics 2012, 5:23.
12.Reimers M, Carey VJ: Bioconductor: an open source framework for bioinformatics and computational biology. Methods Enzymol 2006, 411:119–134.
13.Zhang K, Kong X, Feng G, Xiang W, Chen L, Yang F, Cao C, Ding Y, Chen H, Chu M, et al: Investigation of hypoxia networks in ovarian cancer via bioinformatics analysis. J Ovarian Res 2018, 11:16.
14.Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C, Jensen LJ: STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res 2013, 41:D808–815.
15.Lue HW, Yang X, Wang R, Qian W, Xu RZ, Lyles R, Osunkoya AO, Zhou BP, Vessella RL, Zayzafoon M, et al: LIV–1 promotes prostate cancer epithelial-to-mesenchymal transition and metastasis through HB-EGF shedding and EGFR-mediated ERK signaling. PLoS One 2011, 6:e27720.
16.Jiang J, Sun X, Wu W, Li L, Wu H, Zhang L, Yu G, Li Y: Construction and application of a co-expression network in Mycobacterium tuberculosis. Sci Rep 2016, 6:28422.
17.Wan X, Kong Z, Chu K, Yi C, Hu J, Qin R, Zhao C, Fu F, Wu H, Li Y, Huang Y: Co-expression analysis revealed PTCH1–3’UTR promoted cell migration and invasion by activating miR–101–3p/SLC39A6 axis in non-small cell lung cancer: implicating the novel function of PTCH1. Oncotarget 2018, 9:4798–4813.
18.Miller JA, Cai C, Langfelder P, Geschwind DH, Kurian SM, Salomon DR, Horvath S: Strategies for aggregating gene expression data: the collapseRows R function. BMC Bioinformatics 2011, 12:322.
19.Huang DW, Sherman BT, Tan Q, Collins JR, Alvord WG, Roayaei J, Stephens R, Baseler MW, Lane HC, Lempicki RA: The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol 2007, 8:R183.
20.Freitas MC, Uchida Y, Lassman C, Danovitch GM, Busuttil RW, Kupiec-Weglinski JW: Type I interferon pathway mediates renal ischemia/reperfusion injury. Transplantation 2011, 92:131–138.
21.Zhang X, Ritter JK, Li N: Sphingosine–1-Phosphate Pathway in Renal Fibrosis. Am J Physiol Renal Physiol 2018.
22.Zhang B, Horvath S: A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol 2005, 4:Article17.
23.Langfelder P, Horvath S: WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 2008, 9:559.
24.Li S, Li B, Zheng Y, Li M, Shi L, Pu X: Exploring functions of long noncoding RNAs across multiple cancers through co-expression network. Sci Rep 2017, 7:754.
25.Yang Y, Han L, Yuan Y, Li J, Hei N, Liang H: Gene co-expression network analysis reveals common system-level properties of prognostic genes across cancer types. Nat Commun 2014, 5:3231.
26.Colas C, Pajor AM, Schlessinger A: Structure-Based Identification of Inhibitors for the SLC13 Family of Na(+)/Dicarboxylate Cotransporters. Biochemistry 2015, 54:4900–4908.
27.Zhunussova A, Sen B, Friedman L, Tuleukhanov S, Brooks AD, Sensenig R, Orynbayeva Z: Tumor microenvironment promotes dicarboxylic acid carrier-mediated transport of succinate to fuel prostate cancer mitochondria. Am J Cancer Res 2015, 5:1665–1679.
28.Kim JI, Noh MR, Kim KY, Jang HS, Kim HY, Park KM: Methionine sulfoxide reductase A deficiency exacerbates progression of kidney fibrosis induced by unilateral ureteral obstruction. Free Radic Biol Med 2015, 89:201–208.
29.Katagiri D, Hamasaki Y, Doi K, Negishi K, Sugaya T, Nangaku M, Noiri E: Interstitial renal fibrosis due to multiple cisplatin treatments is ameliorated by semicarbazide-sensitive amine oxidase inhibition. Kidney Int 2016, 89:374–385.
30.Dihazi H, Koziolek MJ, Datta RR, Wallbach M, Jung K, Heise D, Dihazi GH, Markovic I, Asif AR, Muller GA: FABP1 and FABP3 Have High Predictive Values for Renal Replacement Therapy in Patients with Acute Kidney Injury. Blood Purif 2016, 42:202–213.
31.Xu Y, Xie Y, Shao X, Ni Z, Mou S: L-FABP: A novel biomarker of kidney disease. Clin Chim Acta 2015, 445:85–90.
32.Wen CP, Cheng TY, Tsai MK, Chang YC, Chan HT, Tsai SP, Chiang PH, Hsu CC, Sung PK, Hsu YH, Wen SF: All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet 2008, 371:2173–2182.
33.Murphy D, McCulloch CE, Lin F, Banerjee T, Bragg-Gresham JL, Eberhardt MS, Morgenstern H, Pavkov ME, Saran R, Powe NR, et al: Trends in Prevalence of Chronic Kidney Disease in the United States. Ann Intern Med 2016, 165:473–481.
34.Hallan SI, Coresh J, Astor BC, Asberg A, Powe NR, Romundstad S, Hallan HA, Lydersen S, Holmen J: International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 2006, 17:2275–2284.
35.Nath KA: Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992, 20:1–17.
36.Remuzzi G, Bertani T: Pathophysiology of progressive nephropathies. N Engl J Med 1998, 339:1448–1456.
37.Rascio F, Pontrelli P, Accetturo M, Oranger A, Gigante M, Castellano G, Gigante M, Zito A, Zaza G, Lupo A, et al: A type I interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation. J Pathol 2015, 237:72–84.
38.Torres DD, Rossini M, Manno C, Mattace-Raso F, D’Altri C, Ranieri E, Pontrelli P, Grandaliano G, Gesualdo L, Schena FP: The ratio of epidermal growth factor to monocyte chemotactic peptide–1 in the urine predicts renal prognosis in IgA nephropathy. Kidney Int 2008, 73:327–333.
39.Ju W, Nair V, Smith S, Zhu L, Shedden K, Song PXK, Mariani LH, Eichinger FH, Berthier CC, Randolph A, et al: Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker. Sci Transl Med 2015, 7:316ra193.
40.Stuart JM, Segal E, Koller D, Kim SK: A gene-coexpression network for global discovery of conserved genetic modules. Science 2003, 302:249–255.
41.Signal B, Gloss BS, Dinger ME: Computational Approaches for Functional Prediction and Characterisation of Long Noncoding RNAs. Trends Genet 2016, 32:620–637.
42.Mount PF, Power DA: Balancing the energy equation for healthy kidneys. J Pathol 2015, 237:407–410.
43.Zhao S, Dorn J, Napieralski R, Walch A, Diersch S, Kotzsch M, Ahmed N, Hooper JD, Kiechle M, Schmitt M, Magdolen V: Plasmin(ogen) serves as a favorable biomarker for prediction of survival in advanced high-grade serous ovarian cancer. Biol Chem 2017, 398:765–773.
44.Nair S, Lee YH, Rousseau E, Cam M, Tataranni PA, Baier LJ, Bogardus C, Permana PA: Increased expression of inflammation-related genes in cultured preadipocytes/stromal vascular cells from obese compared with non-obese Pima Indians. Diabetologia 2005, 48:1784–1788.